Compare COGT & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | LAUR |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.1B |
| IPO Year | 2018 | 2015 |
| Metric | COGT | LAUR |
|---|---|---|
| Price | $34.21 | $36.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 4 |
| Target Price | $36.21 | ★ $39.63 |
| AVG Volume (30 Days) | ★ 2.2M | 1.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,871,000.00 | ★ $1,484,288,000.00 |
| Revenue This Year | N/A | $14.58 |
| Revenue Next Year | $1,733.58 | $7.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.48 |
| 52 Week Low | $8.80 | $21.53 |
| 52 Week High | $43.73 | $38.28 |
| Indicator | COGT | LAUR |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 62.36 |
| Support Level | $33.26 | $33.10 |
| Resistance Level | $37.69 | $37.91 |
| Average True Range (ATR) | 1.43 | 1.16 |
| MACD | 0.29 | 0.19 |
| Stochastic Oscillator | 78.82 | 71.23 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its reportable segments include Peru and Mexico, of which Mexico derives maximum revenue. Geographically, the company operates in Mexico, Peru and United States.